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Received 10 June 2011; received in revised form 24 August 2011; accepted 26 August 2011A 28-year-old office worker was admitted to hospital
because of left scrotal tenderness and swelling that had
persisted for several weeks. He had no history of asbestos
exposure. Physical examination revealed normal bilateral
testes, mild swelling of the left scrotum without tenderness
and no palpable lymph nodes in the bilateral inguinal
regions. Scrotal ultrasonography showed a left hydrocele.
During the hydrocelectomy, several small papillary lesions
of the vaginalis near epididymis were found. These vagi-
nalis lesions were elastic, approximately 0.3e0.5 cm in
diameter, and not connected with hydrocele. The patho-
logical examination of the specimen suggested a diagnosis
of diffuse papillary mesothelioma of the tunica vaginalis.
Computed tomography (CT) scans of the abdomen showed
no evidence of lymph nodes or distal metastasis.
Pathological analysis after left radical orchiectomy re-
ported a 2.5 cm, grayish papillary tumor and small tumors
located in the tunica vaginalis (Fig. 1). Microscopically, the
mesothelial cells formed a complex tubulopapillary pattern
and invaded the paratesticular tissue. The immunohisto-
chemical examinations showed these mesothelial cells
were positive for calretinin and cytokeratin 5/6, but
negative for Leu-M1 and carcinoembryonic antigen. A
diffuse tubulopapillary malignant mesothelioma of the
tunica vaginalis was confirmed.* Corresponding author. Department of Urology, Mackay Memorial
Hospital, 92, Section 2, Chung-Shan North Road, Taipei, Taiwan.
E-mail address: weiko@ms1.mmh.org.tw (W.-K. Tsai).
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http://dx.doi.org/10.1016/j.jfma.2011.08.024This case is a reminder that an unexpected tumor seen
at hydrocelectomy needs to be investigated thoroughly in
order to determine the treatment and prognosis. In this
case, the patient turned out to have a rare tumor, a diffuse
tubulopapillary malignant mesothelioma of the tunica
vaginalis.
Malignant mesothelioma of the tunica vaginalis is a rare
aggressive neoplasm, and only 223 cases have been re-
ported in the world literature so far. It accounted for
around 0.3e1.4% of all cases of malignant mesothelioma.1 A
history of asbestos exposure has been identified in one-
third of the cases.2 The most common initial presenta-
tions of paratesticular malignant mesothelioma are scrotal
enlargement with hydrocele and paratesticular mass1,2 and
most cases have been diagnosed intraoperatively.
Electron microscopy has been the gold standard for the
diagnosis of mesothelioma. However, the International
Mesothelioma Interest Group recommended that immuno-
histochemical examinations may replace the role of elec-
tron microscopy in indentifying malignant mesothelioma,
on account of their high sensitivity and specificity greater
than 80% for suspicious lesions.3 Tunica malignant meso-
thelioma has been reported to express cytokeratin 7,
cytokeratin 5/6, epithelial membrane antigen, thrombo-
modulin, and calretinin, but not cytokeratin 20, Ber-EP4,
carcinoembryonic antigen or Leu-M1.1,4
In a review of 73 cases, Plas et al. reported that the local
recurrence rate of malignant mesothelioma was as high as
35.7% in the patients undergoing only resection of the
hydrocele wall, as compared with local recurrence rates of& Formosan Medical Association. All rights reserved.
Figure 1 Small tumors at the tunica vaginalis (arrowhead).
58 C.-H. Weng et al.10.5% and 11.5% after scrotal or inguinal orchiectomy,
respectively.2 They also recommended that if radiological
examinations show no lymph node involvement, routine
retroperitoneal lymph node dissection need not to be per-
formed because of the high negative rate. The role of
adjuvant therapy after surgery is unclear. Chemotherapymay somewhat benefit patients with unresectable tumors,
local recurrence or disseminated disease.5 In our case, no
evidence of disease recurrence was found during the
following twelve months without adjuvant therapy.References
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